Quantitative assessment of histological changes in chronic gastritis after eradication of Helicobacter pylori
- PMID: 1401210
- PMCID: PMC495107
- DOI: 10.1136/jcp.45.9.796
Quantitative assessment of histological changes in chronic gastritis after eradication of Helicobacter pylori
Abstract
Aims: To evaluate the effect of 10 day triple treatment on H pylori eradication and associated gastritis.
Methods: Fifty patients with H pylori positive non-ulcer dyspepsia were treated for 10 days with amoxicillin, tinidazole, and bismuth salts. Histological examination of the antral mucosa was performed before (T0), six weeks (T1), and six months (T2) after treatment. The new Sydney classification of gastritis was used, using a score from 0 to 3 to grade degree of inflammation, atrophy, activity (intraepithelial or lamina propria damage) and H pylori.
Results: At T0 all patients had chronic active gastritis. Lymphoid follicules were present in 12 cases. At T1 33 patients were H pylori negative: the score showed a decrease of activity (from 2.5 to 0.54). The result was confirmed at T2 (mean score 0.22). Inflammation decreased from 1.8 to 1.4 at T2. Only one case of follicular gastritis was observed. In H pylori positive patients the scores did not show significant modifications.
Conclusions: Ten day triple treatment is effective in eradicating H pylori in 69% of cases, causing a decrease of the total score for gastritis. Activity, defined by polymorph infiltration, was promptly reduced when H pylori was eradicated. There was a trend to a reduction in inflammation, but atrophy was irreversible.
Similar articles
-
Resolution of gastritis induced by Helicobacter pylori 4-5 weeks after successful eradication of infection using a triple therapy regimen of pantoprazole, amoxycillin and clarithromycin for one week.Digestion. 1999;60(3):286-97. doi: 10.1159/000007673. Digestion. 1999. PMID: 10343145 Clinical Trial.
-
The effect of eradication therapy on histological changes in the gastric mucosa in patients with non-ulcer dyspepsia and Helicobacter pylori infection. Prospective randomized intervention study.Hepatogastroenterology. 1999 May-Jun;46(27):2048-56. Hepatogastroenterology. 1999. PMID: 10430396 Clinical Trial.
-
Helicobacter pylori gastritis and non-ulcer dyspepsia in childhood. Efficacy of one-week triple antimicrobial therapy in eradicating the organism.Ital J Gastroenterol. 1996 Oct-Nov;28(8):430-5. Ital J Gastroenterol. 1996. PMID: 9032584 Clinical Trial.
-
[Therapy of Helicobacter pylori infection: current status].Z Gastroenterol. 1993 Jul-Aug;31(7-8):459-63. Z Gastroenterol. 1993. PMID: 8379235 Review. German.
-
Guidelines for the treatment of Helicobacter pylori in the pediatric population.Ann Pharmacother. 1997 Oct;31(10):1247-9. Ann Pharmacother. 1997. PMID: 9337451 Review.
Cited by
-
Regulation of murine dendritic cell immune responses by Helicobacter felis antigen.Infect Immun. 2006 Aug;74(8):4624-33. doi: 10.1128/IAI.00289-06. Infect Immun. 2006. PMID: 16861650 Free PMC article.
-
Bacterial infection as a cause of cancer.Environ Health Perspect. 1995 Nov;103 Suppl 8(Suppl 8):263-8. doi: 10.1289/ehp.95103s8263. Environ Health Perspect. 1995. PMID: 8741796 Free PMC article. Review.
-
Involvement of myeloid dendritic cells in the development of gastric secondary lymphoid follicles in Helicobacter pylori-infected neonatally thymectomized BALB/c mice.Infect Immun. 2003 Apr;71(4):2153-62. doi: 10.1128/IAI.71.4.2153-2162.2003. Infect Immun. 2003. PMID: 12654837 Free PMC article.
-
Helicobacter pylori-negative gastritis: prevalence and risk factors.Am J Gastroenterol. 2013 Jan;108(1):65-71. doi: 10.1038/ajg.2012.372. Epub 2012 Nov 13. Am J Gastroenterol. 2013. PMID: 23147524 Free PMC article.
-
Gastritis - facts and doubts.Prz Gastroenterol. 2016;11(4):286-295. doi: 10.5114/pg.2016.57793. Epub 2016 Sep 8. Prz Gastroenterol. 2016. PMID: 28053685 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical